Sujal Patel | Founder and Chief Executive Officer |
Anna Mowry | Chief Financial Officer |
Parag Mallick | Founder and Chief Scientist |
Stephanie Yan | Cowen and Company, LLC |
Tejas Savant | Morgan Stanley |
David Delahunt | Goldman Sachs |
Thank you for standing by, and welcome to the Nautilus Biotechnology Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's program is being recorded. And now I would like to introduce your host for today's program, [Alex Carr], Investor Relations.